How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach
British Journal of Dermatology · 30.10.2023 · 189 (Supplement_1) · i3-i10
DOI: 10.1093/bjd/ljad257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Dermatology, online erschienen am 30.10.2023. Verfasst von Anusuya Kawsar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Neoplasms, Skin Diseases, Exanthema. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: L'Oréal Dermatological Beauty, L’Oréal Dermatological Beauty.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) have revolutionized treatment strategies in the field of oncology. Their favourable outcomes in terms of efficacy and side-effect profile can be thwarted by the development of immune-related adverse events (irAEs). Cutaneous irAEs are relatively common in patients undergoing immunotherapy and include common inflammatory dermatoses (e.g. eczematous, psoriasiform and lichenoid phenotypes), maculopapular eruptions, pruritus and immunobullous disorders. Most of these reactions can be managed without ICIs having to be stopped completely; however, there are some life-threatening toxicities that dermatologists and oncologists should be aware of. In this review, we focus on how to recognize the commonly associated cutaneous irAEs, touching upon rarer reactions and red flags; finally, we provide guidance on their management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
- The Leeds Centre for Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
ORCID-Profile: Khawar Hussain
Förderung
- L'Oréal Dermatological Beauty
- L’Oréal Dermatological Beauty
Zitieren
APA
Kawsar, A., Hussain, K., Muinonen-Martin, A. J., & Fearfield, L. (2023). How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach. British Journal of Dermatology, 189(Supplement_1), i3-i10. https://doi.org/10.1093/bjd/ljad257
Vancouver
Kawsar A, Hussain K, Muinonen-Martin AJ, Fearfield L. How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach. British Journal of Dermatology. 2023;189(Supplement_1):i3-i10. doi:10.1093/bjd/ljad257
BibTeX
@article{Kawsar2023,
author = {Kawsar, Anusuya and Hussain, Khawar and Muinonen-Martin, Andrew James and Fearfield, Louise},
title = {How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach},
journal = {British Journal of Dermatology},
year = {2023},
volume = {189},
number = {Supplement_1},
pages = {i3--i10},
doi = {10.1093/bjd/ljad257}
}
EUVIMED